Method of increasing immunological effect

Details Method of increasing immunological effect Method of increasing immunological effect

2011-08-09

2011-08-09

Belyavskyi, Michail (Department: 1644)

Drug, bio-affecting and body treating compositions

Nonspecific immunoeffector, per se ; or nonspecific...

C514S885000

Reexamination Certificate

active

07993660

ABSTRACT:
A method of increasing immunological effect in a patient by administering an effective amount of a primary cell derived biologic to the patient, inducing immune production, blocking immune destruction, and increasing immunological effect in the patient. Methods of treating an immune target, treating a tumor, immune prophylaxis, and preventing tumor escape.

REFERENCES:
patent: 6977072 (2005-12-01), Hadden
patent: 7731945 (2010-06-01), Hadden
patent: 2010/0047205 (2010-02-01), Hadden et al.
Barrera et al ., Arch Otolar.Head Neck Surg, 2000, v.126, 345-351.
Dunn, G., et al.; Dendritic Cells and HNSCC: A Potential Treatment Option? (Review). Oncology Reports 13:3-10 (2005).
Egan, J.E., et al; IRX-2, A Novel In Vivo Immunotherapeutic, Induces Maturation and Activation of Human Dendritic Cells In Vitro. J Immunother 30:624-633 (2007).
Galon, J., et al; Type, Density, and Location of immune Cells Within Human Colorectal Tumors Predict Clinical Outcome. Science 313:1960 (2006).
Hadden, J.W., et al,; Immunotherapy with Natural Interleukins and/or Thymosin Alpha 1, Potently Augments T-Lymphocyte Response of Hydrocortisone-Treated Aged Mice. Int J Immunopharm 17(10):821-828 (1995).
Hadden, J.W., et al: Zinc Induces Thymulin Secretion from Human Thymic Epithelial Cells In Vitro and Augments Splenocytes and Thymocyte Responses In Vivo. Int J Immunopharm 17(9):729-733 (1995).
Kaech, S.M., et al: Effector and Memory T-Cell Differentiation: Implications for Vaccine Development. Nature Rev Immunol 2:251 (2001).
Lanzavecchia, A., et al; Understanding the Generation and Function of memory T Cell Subsets. Curr Opin Immunol 17:326 (2005).
Maass, G., et al; Priming of Tumor-Specific T Cells in the Draining Lymph Nodes After Immunization with Interleukin-2-Secreting Tumor Cells: Three Consecutive Stages May Be Required for Successful Tumor Vaccination. Proc natl Acad Sci 92:5540 (1995).
Mantovani, A., et al; Macrophage Polarization: Tumor Associated Macrophages as a Paradigm for Polarized M2 Mononuclear Phagocytes. Trends in Immunology, 23 (11) (2002).
Meneses, A., et al; Lymph Node Histology in Head and Neck Cancer: Impact of Immunotherapy with IRX-2. Int'l Immunopharm. 3:1083-1091 (2003).
Pages, F., et al; Two Subsets of Memory T Lymphocytes with Distinct Homing Potentials and Effector Functions. nature 401:708 (1999).
Sallusto, F., et al; Two Subsets of Memory T Lymphocytes with Distinct Homing Potential and Effector Functions. Nature 401:708 (1999).
Tomiyama, H., et al; Phenotypic Classification of Human CD8+ T Cells Reflecting Their Function: Inverse Correlations Between Quantitative Expression of CD27 and Cytotoxic Effector Function. Eur J Immunol 34:999 (2004).
Verastegui, E., et al; Immunological Approach in the Evaluation of Regional Lymph Nodes of Patients with Squamous Cell Carcinoma of the Head and Neck. Clin Immunol 102:37 (2002).
Whiteside, T.L.; Immunobiology and Immunotherapy of Head and Neck Cancer. Curr Onc Reports 3:46-55 (2001).
Wolf, G.T., et al; Lymphocyte Subpopulations Infiltration Squamous Carcinomes of the Head and Neck: Correlations with Extent and Tumor Prognosis. Otolarynol Head Neck Surg 95:145 (1986).

Affiliated with

Also associated with

Rating

Method of increasing immunological effect does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of increasing immunological effect, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of increasing immunological effect will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2775025